Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY and GLENN LARKIN

Stryker Stock Sees IBD Relative Strength Rating Improve To 78

The Relative Strength (RS) Rating for Stryker entered a higher percentile Wednesday, as it got a lift from 70 to 78.

As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.

This proprietary rating measures technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.

History reveals that the top-performing stocks often have an RS Rating north of 80 in the early stages of their moves. See if Stryker can continue to show renewed price strength and hit that benchmark.

Looking For The Best Stocks To Buy And Watch? Start Here

Stryker is building a consolidation with a 281.26 buy point. It had a nice gain yesterday in higher volume.  Today it is up again, but on lower volume. See if the stock can clear the breakout price in heavy trade, while keeping in mind earnings are right around the corner.

Earnings Analysis

Stryker showed -4% EPS growth last quarter, while sales growth came in at 10%. Keep an eye out for the company's next round of numbers on or around Apr. 28.

Stryker earns the No. 15 rank among its peers in the Medical-Products industry group. United Guardian and Edwards Lifesciences are also among the group's highest-rated stocks.

​Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.